SEMA3F and neoplasm: Although SEMA3F has been extensively reported to act as a tumor suppressor element by inhibiting cell migration in the context of metastasis [26–29], two recent publications point to a prometastatic role of SEMA3F in hepatocarcinoma [30, 31], thus suggesting that SEMA3F is a suitable poor prognosis marker.